Table 2 Baseline characteristics according to patient survival

Age (yr)

61.8±10.4

68.0±9.7

0.009

Male (%)

11 (45.8)

54 (49.5)

0.742

HD duration (yr)

4.7 [2.6, 9.0]

4.2 [1.6, 7.6]

0.274

Diabetes mellitus (%)

21 (87.5)

70 (64.2)

0.026

Hypertension (%)

24 (100.0)

103 (94.5)

0.591

Cardiovascular disease (%)

21 (87.5)

45 (41.3)

<0.001

Dose of erythropoietin (IU/week)

9000 [4000, 12750]

8000 [3500, 12000]

0.303

Body mass index (kg/m²)

22.9±2.9

23.1±4.5

0.893

Interdialytic weight gain (kg)

2.49±0.88

2.34±0.84

0.457

Kt/V

1.62±0.28

1.66±0.32

0.607

Plasma hemoglobin (g/dL)

10.5±1.2

10.5±0.9

0.783

Glucose (mg/dL)

189.1±76.7

163.9±75.9

0.145

Serum albumin (g/dL)

3.6±0.3

3.8±0.4

0.067

Sodium (mEq/L)

138.0±4.8

138.3±3.6

0.658

Potassium (mEq/L)

5.0±0.9

4.7±0.7

0.077

Serum calcium (mg/dL)

8.9±0.6

8.8±0.8

0.736

Serum phosphorus (mg/dL)

4.4±1.7

4.4±1.4

0.706

Intact PTH (pg/mL)

156.6 [52.2, 474.5]

302 [139.5, 484.3]

0.139

High cortisol group (%)

18 (75.0)

49 (45.0)

0.008

Total cholesterol (mg/dL)

128.6±35.4

134.9±35.5

0.438

LDL-cholesterol (mg/dL)

67.7±22.9

73.3±23.9

0.301

C-reactive protein (mg/L)

2.7 [1.0, 11.2]

1.2 [0.7, 2.9]

0.082

LVH (%)

11 (73.3)

67 (77.9)

0.741

LVSD (%)

5 (33.3)

13 (14.6)

0.131

LVDD (%)

9 (64.3)

44 (51.8)

0.384